Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01112696 · ClinicalTrials.gov registry record · NA
An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor
A NA study, sponsored by Medtronic MiniMed.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT01112696: Completed NA study, sponsored by Medtronic MiniMed.
NCT01112696 is a NA study that has completed, run by Medtronic MiniMed. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01112696, a NA study, has completed, sponsored by Medtronic MiniMed.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
The purpose of the study is to assess the performance of a new subcutaneous glucose sensor over a seven-day sensor life when used with currently marketed Medtronic Diabetes devices. In addition performance will be calculated for use of the new sensor with proposed new devices using new calibration algorithms.
Interventions
- DEVICE Sensor wear
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2010-04 |
| Est. Completion | 2010-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01112696
The ClinicalTrials.gov registry entry for NCT01112696 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medtronic MiniMed, which has 29 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Sensor wear is the first listed.
NCT01112696 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01112696 about?
NCT01112696 is a clinical study titled "An Inpatient Performance Evaluation of a New Subcutaneous Glucose Sensor". The purpose of the study is to assess the performance of a new subcutaneous glucose sensor over a seven-day sensor life when used with currently marketed Medtronic Diabetes devices. In addition performance will be calculated for use of the new sensor with proposed new devices using new calibration a...
What is the current status of trial NCT01112696?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2010-04. Estimated completion is 2010-11.
What interventions are being tested in trial NCT01112696?
The interventions under investigation include: Sensor wear (DEVICE).
Who is sponsoring clinical trial NCT01112696?
This trial is sponsored by Medtronic MiniMed, which has 29 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.